Blood Flow Restriction (BFR) Training on the Ulnar Collateral Ligament (UCL)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorThe Methodist Hospital Research Institute
About this trial
The goal of this clinical trial is to identify any differences in elbow ulnar collateral ligament (UCL) relative thickness and joint space laxity in the dominant arm following an 8-week course of low intensity resistance exercises with blood flow restriction (BFR) exercises in healthy volunteers. The main questions it aims to answer are:
1. Do BFR exercises contribute to a change in the relative ligament thickness of the UCL, and changes in the ulnohumeral joint space? 2. Are there changes in arm strength following the 8-week strengthening protocol with/without BFR?
Participants will:
* Complete two BFR sessions a week for a total of eight weeks. * Complete an exercise session with both arms (dominant arm will receive BFR) at each study visit. * Have sonographs taken of the UCL at the first and last study visit. * Complete strength assessments at the first and last study visit.
Eligibility criteria
Qualifiers
Healthy volunteer
Agree to complete all exercise sessions and program in its entirety
Between the ages of 18-50 years old
Disqualifiers
Current or recent injury of the hand, elbow, or shoulder
Outside of the ages of 18-50 years old
Vascular compromise or previous vascular surgery
History of DVT
Trial design
Treatments tested in this trial
- Delfi PTS Blood Flow Restriction Tourniquet System
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov